Success Metrics

Clinical Success Rate
95.7%

Based on 44 completed trials

Completion Rate
96%(44/46)
Active Trials
19(22%)
Results Posted
14%(6 trials)
Terminated
2(2%)

Phase Distribution

Ph phase_4
2
2%
Ph phase_1
2
2%
Ph not_applicable
74
87%
Ph phase_2
2
2%
Ph phase_3
4
5%

Phase Distribution

2

Early Stage

2

Mid Stage

6

Late Stage

Phase Distribution84 total trials
Phase 1Safety & dosage
2(2.4%)
Phase 2Efficacy & side effects
2(2.4%)
Phase 3Large-scale testing
4(4.8%)
Phase 4Post-market surveillance
2(2.4%)
N/ANon-phased studies
74(88.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

89.8%

44 of 49 finished

Non-Completion Rate

10.2%

5 ended early

Currently Active

19

trials recruiting

Total Trials

85

all time

Status Distribution
Active(24)
Completed(44)
Terminated(5)
Other(12)

Detailed Status

Completed44
Recruiting17
unknown12
Not yet recruiting3
Withdrawn3
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
85
Active
19
Success Rate
95.7%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (2.4%)
Phase 22 (2.4%)
Phase 34 (4.8%)
Phase 42 (2.4%)
N/A74 (88.1%)

Trials by Status

unknown1214%
terminated22%
active_not_recruiting22%
enrolling_by_invitation22%
recruiting1720%
completed4452%
not_yet_recruiting34%
withdrawn34%

Recent Activity

Clinical Trials (85)

Showing 20 of 85 trialsScroll for more
NCT07617467Not Applicable

Group-based ACT for Psychological Distress of Young People

Recruiting
NCT05878795Not Applicable

Written Exposure Therapy for Suicide Prevention

Recruiting
NCT07497763Not Applicable

A Brief Case Management Intervention to Promote Personal Recovery and Prevent Psychiatric Involuntary Readmissions.

Not Yet Recruiting
NCT03363256Not Applicable

Web-based Addiction Treatment: Cultural Adaptation With American Indians

Completed
NCT05118204Phase 4

Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization

Terminated
NCT06835556Not Applicable

Volatility in Paranoia (VIP) Trial: An RCT of Changes in Volatility With Psychotherapy

Recruiting
NCT06054061Not Applicable

Evaluation the Efficacy "Think and Cope Positively" Program

Completed
NCT05642715Not Applicable

Trial of a Harm Reduction Strategy for People With HIV Who Smoke Cigarettes

Recruiting
NCT04986228Not Applicable

DigiPuR: Digitally Supported Psychotherapy and Reintegration

Completed
NCT06803043Not Applicable

Evaluation of a Trauma-Informed Partner Violence Intervention Program

Enrolling By Invitation
NCT06192602Not Applicable

Effects of an Acceptance-based Medication Adherence Therapy for Recent-onset Psychosis

Active Not Recruiting
NCT05380583Not Applicable

Community Reinforcement and Family Training for Early Psychosis (CRAFT-EP) and Substance Use: A Pilot Study

Completed
NCT05843695Not Applicable

Enhancing Psychotherapy for Veterans and Service Members With PTSD and Anxiety

Recruiting
NCT05423444Not Applicable

Neural Connectivity During Therapy for Adolescent PTSD

Recruiting
NCT07242625Not Applicable

A Pilot Study on Efficacy of Digital Therapeutic NDTx-02 for Executive Function in Children and Adolescents With ADHD or ASD

Recruiting
NCT06536634Not Applicable

Effects and Mechanisms of Sensory Afferent Electrostimulation on Upper Limb Function in Patients With Hemiparesis

Recruiting
NCT03755401Not Applicable

Post-Traumatic Stress Disorder Focused Psychodynamic Psychotherapy

Recruiting
NCT05488691Not Applicable

Eye Movement Desensitization and Reprocessing as a Treatment for Substance Use Disorders

Completed
NCT06444256Phase 2

Orexin Receptor Antagonism and Sleep in Stimulant Use Disorder

Recruiting
NCT04436757Not Applicable

Self and Body-esteem in Socio-professional Rehabilitation

Completed

Drug Details

Intervention Type
OTHER
Total Trials
85